DOXIL is a Intravenous Injection, Suspension, Liposomal in the Human Prescription Drug category. It is labeled and distributed by Janssen Products, Lp. The primary component is Doxorubicin Hydrochloride.
| Product ID | 59676-960_17206b15-725c-410d-838d-ccb228c6ea2b |
| NDC | 59676-960 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DOXIL |
| Generic Name | Doxorubicin Hydrochloride |
| Dosage Form | Injection, Suspension, Liposomal |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1995-11-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050718 |
| Labeler Name | Janssen Products, LP |
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
| Active Ingredient Strength | 2 mg/mL |
| Pharm Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1995-11-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050718 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1995-11-17 |
| Marketing End Date | 2020-06-30 |
| Marketing Category | NDA |
| Application Number | NDA050718 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1995-11-17 |
| Marketing End Date | 2020-09-30 |
| Ingredient | Strength |
|---|---|
| DOXORUBICIN HYDROCHLORIDE | 2 mg/mL |
| SPL SET ID: | 21d9c619-7e94-49e2-ac41-31e9ea96554a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59676-960 | DOXIL | DOXIL |
| 0338-0063 | DOXIL | DOXIL |
| 0338-0067 | DOXIL | DOXIL |
| 0069-3030 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
| 0069-3031 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
| 0069-3032 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
| 0069-3033 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
| 0069-3034 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
| 0069-4004 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
| 0069-4015 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
| 0069-4026 | Doxorubicin Hydrochloride | Doxorubicin Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DOXIL 74223789 1744235 Live/Registered |
BAXTER HEALTHCARE CORPORATION 1991-11-21 |